Pallas Capital Advisors’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.23M Sell
10,932
-1,733
-14% -$515K 0.12% 147
2025
Q4
$3.46M Sell
12,665
-850
-6% -$231K 0.11% 144
2025
Q3
$3.65M Sell
13,515
-476
-3% -$130K 0.13% 126
2025
Q2
$3.86M Buy
13,991
+148
+1% +$40.2K 0.15% 116
2025
Q1
$3.67M Buy
13,843
+6,281
+83% +$1.55M 0.15% 124
2024
Q4
$1.76M Buy
7,562
+454
+6% +$104K 0.08% 163
2024
Q3
$1.63M Buy
+7,108
New +$1.47M 0.07% 166
2021
Q3
Sell
-3,248
Closed -$677K 404
2021
Q2
$677K Sell
3,248
-12
-0.4% -$2.53K 0.1% 158
2021
Q1
$678K Buy
+3,260
New +$642K 0.15% 112

Other funds holding CME

Pallas Capital Advisors's CME Position: Q1 2026 in Review

Pallas Capital Advisors reduced its CME Group (CME) stake by 14% in Q1 2026, selling an estimated $515K and leaving 10,932 shares worth $3.23M. The position accounts for 0.12% of the portfolio, ranked #147.

Pallas Capital Advisors first reported a position in CME in Q1 2021 and has held it in 9 quarters since. The position peaked at $3.86M in Q2 2025. 1,791 funds tracked by Wall St. Rank hold CME as of Q1 2026.

  • Pallas Capital Advisors held 10,932 shares of CME Group worth $3.23M as of Q1 2026.
  • Pallas Capital Advisors sold 1,733 CME Group shares in Q1 2026, an estimated $515K.
  • CME Group made up 0.12% of Pallas Capital Advisors's portfolio in Q1 2026, its #147 holding.
  • Pallas Capital Advisors first reported a position in CME Group in Q1 2021 and has held it in 9 quarters since.
  • Pallas Capital Advisors's CME Group position peaked at $3.86M in Q2 2025.
  • 1,791 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on Pallas Capital Advisors's 13F filing for Q1 2026, filed 21 Apr 2026.